These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23164484)

  • 1. Inflammation in COPD: implications for management.
    Sethi S; Mahler DA; Marcus P; Owen CA; Yawn B; Rennard S
    Am J Med; 2012 Dec; 125(12):1162-70. PubMed ID: 23164484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
    Prescrire Int; 2016 Nov; 25(176):272-277. PubMed ID: 30715829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
    Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airways inflammation and treatment during acute exacerbations of COPD.
    Bathoorn E; Kerstjens H; Postma D; Timens W; MacNee W
    Int J Chron Obstruct Pulmon Dis; 2008; 3(2):217-29. PubMed ID: 18686731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple combinations in chronic obstructive pulmonary disease - is three better than two?
    Cazzola M; Matera MG
    Expert Opin Pharmacother; 2014 Dec; 15(17):2475-8. PubMed ID: 25327264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment of stable COPD: need for a simplified approach.
    Hillas G; Papaporfyriou A; Dimakou K; Papaioannou AI
    Postgrad Med; 2020 Mar; 132(2):126-131. PubMed ID: 31852408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
    Albertson TE; Chenoweth JA; Pearson SJ; Murin S
    Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
    [No Abstract]   [Full Text] [Related]  

  • 8. The Asthma-COPD Overlap Syndrome.
    Postma DS; Rabe KF
    N Engl J Med; 2015 Sep; 373(13):1241-9. PubMed ID: 26398072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Approach to the Therapy of Asthma-COPD Overlap.
    Maselli DJ; Hardin M; Christenson SA; Hanania NA; Hersh CP; Adams SG; Anzueto A; Peters JI; Han MK; Martinez FJ
    Chest; 2019 Jan; 155(1):168-177. PubMed ID: 30077690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
    Hizawa N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
    Wurst KE; Shukla A; Muellerova H; Davis KJ
    COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
    Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
    Gosens R; Zaagsma J; Meurs H; Halayko AJ
    Respir Res; 2006 May; 7(1):73. PubMed ID: 16684353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics Outlook.
    Rabe KF; Rennard S; Martinez FJ; Celli BR; Singh D; Papi A; Bafadhel M; Heble J; Radwan A; Soler X; Jacob Nara JA; Deniz Y; Rowe PJ
    Am J Respir Crit Care Med; 2023 Aug; 208(4):395-405. PubMed ID: 37348121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic obstructive pulmonary disease: the right treatment for the right patient].
    Olschewski H; Buhl R; Funk GC; Valipour A; Vogelmeier CF
    Internist (Berl); 2021 Jun; 62(6):679-685. PubMed ID: 33860810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging therapeutic strategies in COPD.
    Babu KS; Morjaria JB
    Drug Discov Today; 2015 Mar; 20(3):371-9. PubMed ID: 25462534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
    Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications.
    Tamimi A; Serdarevic D; Hanania NA
    Respir Med; 2012 Mar; 106(3):319-28. PubMed ID: 22196881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
    Pelaia G; Muzzio CC; Vatrella A; Maselli R; Magnoni MS; Rizzi A
    Expert Opin Pharmacother; 2015; 16(13):2009-21. PubMed ID: 26194120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults.
    Fingleton J; Travers J; Williams M; Charles T; Bowles D; Strik R; Shirtcliffe P; Weatherall M; Beasley R;
    J Allergy Clin Immunol; 2015 Sep; 136(3):601-9. PubMed ID: 25746966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.